LION vs TECH · rev $3.20B vs P/E 65, rev $1.22B
Lionsgate Studios Holding Corp. (to be renamed Lionsgate Studios Corp.) (LION) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Lionsgate Studios Holding Corp. (to be renamed Lionsgate Studios Corp.) (LION) is a shell companies company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported LION revenue for 2025-03-31 was $3.20B. Net income was -$126.9M. Revenue was up 7.0% from 2024-03-31 to 2025-03-31. LION currently screens at market cap $1.67B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
LION currently screens at market cap $1.67B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the LION and TECH stock pages for the full models.
Not investment advice.